Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Spectrum Pharma: Fusilev Bubble Will Burst
TheStreet.com
Friday, April 29, 2011 - 11:16am
tags:
Fusilev, Spectrum Pharmaceuticals, colon cancer
EU probes whether deal to keep generic Provigil off European market broke competition rules
Yahoo/AP
Friday, April 29, 2011 - 11:14am
tags:
generics, Provigil, Europe, Teva Pharmaceuticals, Cephalon
Allergan Must Pay $212M Over Botox Side Effects
Pharmalot
Friday, April 29, 2011 - 10:18am
tags:
Allergan, Botox, settlements
Are Top-Earning Pharma CEOs (We Mean You, William Weldon) Worth the $$$?
WSJ Online
Friday, April 29, 2011 - 10:17am
tags:
Pharma CEOs, executive pay, William Weldon, JNJ
4-Star Stocks Poised to Pop: AstraZeneca
Motley Fool
Friday, April 29, 2011 - 10:16am
tags:
AstraZeneca
Merck Profit Tops Analyst Estimates on Higher Drug Sales
Bloomberg
Friday, April 29, 2011 - 10:15am
tags:
Merck, earnings
Human Genome Sciences books bigger 1Q loss
Yahoo/AP
Thursday, April 28, 2011 - 10:05pm
tags:
Human Genome Sciences, earnings
1 Year to P-Day, Bristol-Myers Squibb Looks Just Fine
Motley Fool
Thursday, April 28, 2011 - 10:04pm
tags:
Plavix, patents, Bristol-Myers Squibb
FDA panel unanimously favors approval for experimental hepatitis drug from Vertex Pharma
Yahoo/AP
Thursday, April 28, 2011 - 10:01pm
tags:
FDA, Vertex Pharmaceuticals, advisory panels, hepatitis C, Telaprevir
Merck KGaA Beats, Raises Outlook
Yahoo/Zacks.com
Thursday, April 28, 2011 - 10:00pm
tags:
earnings, Merck KGaA
Johnson & Johnson Prostate Cancer Drug Approved by U.S. FDA
Bloomberg
Thursday, April 28, 2011 - 10:00pm
tags:
prostate cancer, JNJ, FDA, abiraterone
All Eyes Are On Roche, Lucentis And Avastin
Pharmalot
Thursday, April 28, 2011 - 1:26pm
tags:
Roche, Lucentis, Avastin
Ranbaxy, FDA Ask Judge to Toss Mylan Suit Over Lipitor Copy
Bloomberg
Thursday, April 28, 2011 - 12:58pm
tags:
FDA, Ranbaxy, Mylan, generics, Lipitor, Pfizer
Genzyme Q1 revenue up
Bizjournals.com
Thursday, April 28, 2011 - 12:52pm
tags:
earnings, Genzyme
Alternative Vaccine Manufacturers: Novavax and Ibio
Seeking Alpha
Thursday, April 28, 2011 - 9:46am
tags:
Novavax, iBio, vaccines
Pfizer arthritis drug meets main goals of studies
Reuters
Thursday, April 28, 2011 - 9:45am
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Teva Positioned to Acquire Spectrum Pharmaceuticals After Fusilev Approval
Seeking Alpha
Thursday, April 28, 2011 - 9:42am
tags:
Teva Pharmaceuticals, Spectrum Pharmaceuticals, Fusilev, M&A
Par Pharmaceutical settles drug pricing lawsuits
Reuters
Thursday, April 28, 2011 - 9:41am
tags:
Par Pharmaceutical, lawsuits, drug pricing
Intercell, Merck S. Aureus Shot Safe, Effective in Renal Disease
Bloomberg
Thursday, April 28, 2011 - 9:26am
tags:
Intercell, Merck, vaccines, renal disease, V710
Regeneron: A Great Lesson to Learn
Seeking Alpha
Thursday, April 28, 2011 - 9:06am
tags:
Regeneron, Zaltrap

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.